ACTIVE

Apotheek DE ZWAANTJES

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result78,3 k €+62,0 %over 1 year
Gross margin396,9 k €-3,9 %over 1 year
Equity369,9 k €+18,7 %over 1 year
Workforce3,6 ETP+2,9 %over 1 year

Identity

Source · BCE/KBO

Apotheek DE ZWAANTJES is a Private limited company incorporated in 1968. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Malle. It employs on average 3,6 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0403.858.411
Incorporation
01/01/1968
Legal form
Private limited company
Registered office
Antwerpsesteenweg 281
2390 Malle · FlandreSee on map
Contributed capital
18 600,00 €
Latest accounts
31/12/2025
Average workforce
3,6 ETP
Joint committees (1)
  • 313
Contacts
1 public detail availableLog in to view
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 20 filings

Trend over 20 financial years

20252024202320222021
Income statement
Gross margin396,9 k €412,9 k €407 k €408,3 k €357,7 k €
EBITDA126,1 k €148,3 k €142,7 k €136,3 k €168,7 k €
Operating result113,4 k €79,5 k €74 k €69,1 k €103,9 k €
Net result78,3 k €48,3 k €43,5 k €39,7 k €85,6 k €
Balance sheet
Equity369,9 k €311,6 k €263,3 k €219,8 k €180,1 k €
Total assets806,1 k €690,2 k €694,2 k €759,6 k €753,8 k €
Cash323,2 k €248,8 k €184,1 k €159,6 k €125,8 k €
Debts426 k €358,8 k €429,7 k €534 k €573,7 k €
Other
Workforce3,6 ETP3,5 ETP3,8 ETP4,1 ETP3,4 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

3 active · 16 ended

Active mandates

Joris Schoofs

Director · since 01 février 2024

Active
K-FARMA

Director · since 01 février 2024 · 1001.785.712

Represented by Kaat Vandersteen

Active
ROEL FIEY MANAGEMENT

Director · since 01 février 2024 · 0541.546.842

Represented by Roel Fiey

Active

Ended mandates

K-FARMA

Director · since 01 février 2024 · 1001.785.712

Represented by Kaat Vandersteen

Ended
ROEL FIEY MANAGEMENT

Director · since 01 février 2024 · 0541.546.842

Represented by Roel Fiey

Ended
VERLINDEN PHARMA

Manager · since 01 février 2015 · 0863.135.296

Represented by Erwin Veltjen

Ended
REMEDIA

Manager · since 06 février 2009 · 0808.150.154

Represented by Firmin Boonen

Ended

Other companies at this address

Antwerpsesteenweg 281 2390 Malle
CompanyCBE no.
APOTHEEK MANAGEMENT OP MAAT● Active
0827.396.142

Full financial information

Source · NBB
202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date29/06/202630/06/202517/01/202515/05/202325/07/202216/07/2021
General meeting22/06/202623/06/202528/03/202428/04/202320/07/202230/06/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 20 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202522/06/202629/06/2026DutchPDF
Abridged model31/12/202423/06/202530/06/2025DutchPDF
Abridged model31/12/202328/03/202417/01/2025DutchPDF
Abridged model31/12/202228/04/202315/05/2023DutchPDF
Abridged model31/12/202120/07/202225/07/2022DutchPDF
Abridged model31/12/202030/06/202116/07/2021DutchPDF
Abridged model31/12/201907/08/202031/08/2020DutchPDF
Abridged model31/12/201817/06/201930/08/2019DutchPDF
Abridged model31/12/201718/06/201830/08/2018DutchPDF
Abridged model31/12/201619/06/201731/08/2017DutchPDF
Abridged model31/12/201520/06/201601/08/2016DutchPDF
Abridged model31/12/201422/06/201526/08/2015DutchPDF
Abridged model31/12/201315/05/201431/07/2014DutchPDF
Abridged model31/12/201217/06/201301/08/2013DutchPDF
Abridged model31/12/201118/06/201226/07/2012DutchPDF
Abridged model31/12/201020/06/201108/08/2011DutchPDF
Abridged model31/12/200921/06/201013/08/2010DutchPDF
Abridged model31/12/200806/06/200917/08/2009DutchPDF
Abridged model31/12/200707/06/200828/08/2008DutchPDF
Abridged model31/12/200602/06/200702/07/2007DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

3 active · 16 ended

Active mandates

Joris Schoofs

Director · since 01 février 2024

Active
K-FARMA

Director · since 01 février 2024 · 1001.785.712

Represented by Kaat Vandersteen

Active
ROEL FIEY MANAGEMENT

Director · since 01 février 2024 · 0541.546.842

Represented by Roel Fiey

Active

Ended mandates

K-FARMA

Director · since 01 février 2024 · 1001.785.712

Represented by Kaat Vandersteen

Ended
ROEL FIEY MANAGEMENT

Director · since 01 février 2024 · 0541.546.842

Represented by Roel Fiey

Ended
VERLINDEN PHARMA

Manager · since 01 février 2015 · 0863.135.296

Represented by Erwin Veltjen

Ended
REMEDIA

Manager · since 06 février 2009 · 0808.150.154

Represented by Firmin Boonen

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates21/03/2024
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates10/10/2023
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates04/11/2021
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates08/01/2020
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Registered office16/11/2016
    MAATSCHAPPELIJKE ZETEL
    PDF
  • Mandates17/02/2015
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Other23/06/2011
    BENAMING
    PDF
  • Mandates25/02/2009
    BENAMING - MAATSCHAPPELIJKE ZETEL - ONTSLAGEN - BENOEMINGEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 202578,3 k €↑
  2. 2024
    Annual accounts 202448,3 k €↑
  3. 2023
    Annual accounts 202343,5 k €↑
  4. 2022
    Annual accounts 202239,7 k €↓
  5. 2021
    Annual accounts 202185,6 k €↑
  6. 2020
    Annual accounts 202057,6 k €↑
  7. 2019
    Annual accounts 2019-9,4 k €↑
  8. 2018
    Annual accounts 2018-48,5 k €↓
  9. 2017
    Annual accounts 2017-43,6 k €↓
  10. 2016
    Annual accounts 2016-19,3 k €↑
  11. 2015
    Annual accounts 2015-35,2 k €↓
  12. 2014
    Annual accounts 20146,6 k €↑
  13. 2013
    Annual accounts 20132 k €↓
  14. 2012
    Annual accounts 201210,7 k €↑
  15. 2011
    Annual accounts 2011-15,9 k €↓
  16. 2010
    Annual accounts 2010-3,5 k €↓
  17. 2010
    Name changeApotheek DE ZWAANTJES
  18. 2009
    Annual accounts 200952,3 k €↑
  19. 2008
    Annual accounts 2008-1,3 k €↓
  20. 2008
    Name changeAPOTHEEK A. VAN GENECHTEN
  21. 2007
    Annual accounts 200719,7 k €↑
  22. 2006
    Annual accounts 2006-50,1 k €
  23. 2006
    Name changeVan Den Bosch, Apoteek
  24. 01/01/1968
    IncorporationPrivate limited company